Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

JoAnn E. Manson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9426-7595; OpenAlex author ID A5049411008. Sources: OpenAlex.

Their work

Papers
18 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2012: 1 paper · 2013: 3 papers · 2014: 1 paper · 2015: none · 2016: 4 papers · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 18

  1. Risk Factors for Pancreatic Cancer among Nonsmokers and Nondrinkers of Alcohol in the Women's Health Initiative. First author DOI 10.1158/1055-9965.epi-25-0745↗
  2. Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. Co-author DOI 10.1158/1055-9965.epi-23-0505↗
  3. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. Co-author DOI 10.14309/ctg.0000000000000573↗
  4. Prediagnostic Inflammation and Pancreatic Cancer Survival. Co-author DOI 10.1093/jnci/djab040↗
  5. Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Co-author DOI 10.1158/1055-9965.epi-19-1389↗
  6. Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. Co-author DOI 10.1158/1055-9965.epi-19-0577↗
  7. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studie… Co-author DOI 10.1053/j.gastro.2017.12.001↗
  8. Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2016-312510↗
  9. Cigarette Smoking and Pancreatic Cancer Survival. Co-author DOI 10.1200/jco.2016.71.2026↗
  10. Prospective analysis of association between statins and pancreatic cancer risk in the Women's Health Initiative. Last author DOI 10.1007/s10552-016-0717-6↗
  11. Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. Co-author DOI 10.1093/jnci/djv409↗
  12. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Co-author DOI 10.1158/0008-5472.can-16-1699↗
  13. Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival. Co-author DOI 10.1200/jco.2015.66.3005↗
  14. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Co-author DOI 10.1038/nm.3686↗
  15. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. Co-author DOI 10.1093/jnci/djs474↗
  16. Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. Co-author DOI 10.1093/jnci/djt123↗
  17. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Co-author DOI 10.1158/1055-9965.epi-12-1458↗
  18. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-11-0836↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Edward L. Giovannucci · 16 shared papers, 2012–2023 · strength 0.97
  2. Peter Kraft · 16 shared papers, 2012–2023 · strength 0.97
  3. Brian Matthew Wolpin · 16 shared papers, 2012–2023 · strength 0.97
  4. Charles S. Fuchs · 16 shared papers, 2012–2023 · strength 0.97
  5. Chen Yuan · 12 shared papers, 2014–2023 · strength 0.87
  6. Kimmie Ng · 12 shared papers, 2012–2023 · strength 0.86
  7. Ana Babić · 10 shared papers, 2016–2023 · strength 0.80
  8. Thomas E. Rohan · 4 shared papers, 2016–2025 · strength 0.60
  9. Vicente Morales‐Oyarvide · 7 shared papers, 2016–2021 · strength 0.43
  10. Rita Peila · 1 shared paper, 2025 · strength 0.42
  11. Jihye Kim · 3 shared papers, 2020–2023 · strength 0.36
  12. Ying Bao · 8 shared papers, 2012–2020 · strength 0.36
  13. Jean Wactawski‐Wende · 4 shared papers, 2012–2023 · strength 0.33
  14. Zhi Rong Qian · 8 shared papers, 2013–2017 · strength 0.32
  15. Laufey Thora Amundadottir · 5 shared papers, 2016–2020 · strength 0.29
  16. Alice A. Lee · 2 shared papers, 2023 · strength 0.28
  17. Qiao-Li Wang Wang · 2 shared papers, 2023 · strength 0.28
  18. Fred K. Tabung · 2 shared papers, 2021–2023 · strength 0.24
  19. Kimberly J. Perez · 2 shared papers, 2021–2023 · strength 0.24
  20. Natalia I. Khalaf · 3 shared papers, 2018–2021 · strength 0.24
  21. Michaël Pollak · 6 shared papers, 2013–2020 · strength 0.24
  22. Jonathan Andrew Nowak · 2 shared papers, 2019–2023 · strength 0.21
  23. Juhua Luo · 2 shared papers, 2016–2023 · strength 0.18
  24. Douglas Adam Rubinson · 4 shared papers, 2014–2017 · strength 0.17
  25. Mingfeng Zhang · 3 shared papers, 2016–2019 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.